Pharmafile Logo

Webinar: Understanding the Patient Journey in China 2015

January 6, 2016 | Chinese Healthcare, Patient journey 

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change. 

Most recently there are concerns that the devaluation in China’s currency has impacted significantly on the local healthcare demand and that the much publicised healthcare reforms that were due to take effect this year have stalled in the implementation. 

Now more than ever, the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

Register now for the latest in our China webinar series where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the Government’s healthcare reforms on the patient journey and consider the possible implication for market researchers.

Our Emerging Markets experts Marc Yates and Rachel Howard will also be considering the impact of China’s more recent financial challenges including the lack of growth within the private sector.

Gain answers to your key questions:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms 
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view the webinar please visit: bit.ly/1O05iUJ

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research Partnership launches new patient Living With Non-alcoholic Steatohepatitis (NASH) report

Living with Non-alcoholic Steatohepatitis (NASH) is a study conducted amongst 100 adults with NASH in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

EULAR Annual European Congress of Rheumatology 2017

Join us at EULAR Congress 2017 in Madrid, 14-17 June

20 questions: Round 2

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What do you love about your job?"Watch the video: http://bit.ly/2qA1oP9

Taking an integrated approach to research

Director Melinda Shorr and Associate Director Steven Helm discuss the benefits of integrated research techniques.Watch the video: http://bit.ly/2qF0qO2

Online Community Research

What to consider when running an online research community?

Research Partnership appoints Helen Parfitt as Director, Head of Therapy Watch

Helen Parfitt has joined Research Partnership as Head of Therapy Watch at the company’s global head office in London. Therapy Watch is a ‘real-time’ syndicated global market tracking tool that...

Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in...

A safe place to talk about Crohn’s

Published in eyeforpharma April 2017 by Mariel Metcalfe

Patient Assistance Programme Evaluation for Cardiovascular Conditions

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.